|
1
|
Abalos E, Duley L, Steyn DW and Gialdini
C: Antihypertensive drug therapy for mild to moderate hypertension
during pregnancy. Cochrane Database Syst Rev.
10:CD0022522018.PubMed/NCBI
|
|
2
|
Magee LA, Pels A, Helewa M, Rey E, von
Dadelszen P, Magee LA, Audibert F, Bujold E, Côté A-M, Douglas MJ,
et al Canadian Hypertensive Disorders of Pregnancy Working Group, :
Diagnosis, evaluation, and management of the hypertensive disorders
of pregnancy: Executive summary. J Obstet Gynaecol Can. 36:416–441.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bramham K, Parnell B, Nelson-Piercy C,
Seed PT, Poston L and Chappell LC: Chronic hypertension and
pregnancy outcomes: Systematic review and meta-analysis. BMJ.
348:g23012014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gini R, Schuemie MJ, Mazzaglia G, Lapi F,
Francesconi P, Pasqua A, Bianchini E, Montalbano C, Roberto G,
Barletta V, et al: Automatic identification of type 2 diabetes,
hypertension, ischaemic heart disease, heart failure and their
levels of severity from Italian General Practitioners electronic
medical records: A validation study. BMJ Open. 6:e0124132016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Z and Rana TM: Therapeutic targeting of
microRNAs: Current status and future challenges. Nat Rev Drug
Discov. 13:622–638. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Muñoz-Culla M, Irizar H, Castillo-Triviño
T, Sáenz-Cuesta M, Sepúlveda L, Lopetegi I, López de Munain A,
Olascoaga J, Baranzini SE and Otaegui D: Blood miRNA expression
pattern is a possible risk marker for natalizumab-associated
progressive multifocal leukoencephalopathy in multiple sclerosis
patients. Mult Scler. 20:1851–1859. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kukreja RC, Yin C and Salloum FN:
MicroRNAs: New players in cardiac injury and protection. Mol
Pharmacol. 80:558–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong X, Liu S, Zhang L, Yu S, Huo L, Qile
M, Liu L, Yang B and Yu J: Downregulation of miR-21 is involved in
direct actions of ursolic acid on the heart: Implications for
cardiac fibrosis and hypertrophy. Cardiovasc Ther. 33:161–167.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mitchell A, Misialek JR, Folsom AR, Duprez
D, Alonso A, Jerosch-Herold M, Sanchez OA, Watson KE, Sallam T and
Konety SH: Usefulness of N-terminal pro-brain natriuretic peptide
and myocardial perfusion in asymptomatic adults (from the
multi-ethnic study of atherosclerosis). Am J Cardiol.
115:1341–1345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams KF Jr, Giblin EM, Pearce N and
Patterson JH: Integrating new pharmacologic agents into heart
failure care: Role of heart failure practice guidelines in meeting
this challenge. Pharmacotherapy. 37:645–656. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McMurray JJ, Adamopoulos S, Anker SD,
Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C,
Gomez-Sanchez MA, et al Task Force for the Diagnosis and Treatment
of Acute and Chronic Heart Failure 2012 of the European Society of
Cardiology; ESC Committee for Practice Guidelines, : ESC guidelines
for the diagnosis and treatment of acute and chronic heart failure
2012: The Task Force for the Diagnosis and Treatment of Acute and
Chronic Heart Failure 2012 of the European Society of Cardiology.
Developed in collaboration with the Heart Failure Association (HFA)
of the ESC. Eur J Heart Fail. 14:803–869. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bredy C, Ministeri M, Kempny A,
Alonso-Gonzalez R, Swan L, Uebing A, Diller GP, Gatzoulis MA and
Dimopoulos K: New York Heart Association (NYHA) classification in
adults with congenital heart disease: Relation to objective
measures of exercise and outcome. Eur Heart J Qual Care Clin
Outcomes. 4:51–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brown MA, Magee LA, Kenny LC, Karumanchi
SA, McCarthy FP, Saito S, Hall DR, Warren CE, Adoyi G and Ishaku S:
Hypertensive disorders of pregnancy: ISSHP classification,
diagnosis, and management recommendations for international
practice. Hypertension. 72:24–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barasa A, Rosengren A, Sandstrom TZ,
Ladfors L and Schaufelberger M: Heart failure in late pregnancy and
postpartum: Incidence and long-term mortality in Sweden from 1997
to 2010. J Card Fail. 23:370–378. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Theilen LH, Fraser A, Hollingshaus MS,
Schliep KC, Varner MW, Smith KR and Esplin MS: All-cause and
cause-specific mortality after hypertensive disease of pregnancy.
Obstet Gynecol. 128:238–244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumarswamy R, Volkmann I and Thum T:
Regulation and function of miRNA-21 in health and disease. RNA
Biol. 8:706–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Berger R, Moertl D, Peter S, Ahmadi R,
Huelsmann M, Yamuti S, Wagner B and Pacher R: N-terminal pro-B-type
natriuretic peptide-guided, intensive patient management in
addition to multidisciplinary care in chronic heart failure a
3-arm, prospective, randomized pilot study. J Am Coll Cardiol.
55:645–653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du Y, Fu J, Yao L, Qiao L, Liu N, Xing Y
and Xue X: Altered expression of PPAR-γ and TRPC in neonatal rats
with persistent pulmonary hypertension. Mol Med Rep. 16:1117–1124.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patrick DM, Montgomery RL, Qi X, Obad S,
Kauppinen S, Hill JA, van Rooij E and Olson EN: Stress-dependent
cardiac remodeling occurs in the absence of microRNA-21 in mice. J
Clin Invest. 120:3912–3916. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu H, Wang J, Ma H, Xiao Z and Dong X:
MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid.
Oncotarget. 8:92914–92925. 2017.PubMed/NCBI
|
|
23
|
Stokes MB, Bergin P and McGiffin D: Role
of long-term mechanical circulatory support in patients with
advanced heart failure. Intern Med J. 46:530–540. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kovács Á, Alogna A, Post H and Hamdani N:
Is enhancing cGMP-PKG signalling a promising therapeutic target for
heart failure with preserved ejection fraction? Neth Heart J.
24:268–274. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cavagna L, Caporali R, Klersy C, Ghio S,
Albertini R, Scelsi L, Moratti R, Bonino C and Montecucco C:
Comparison of brain natriuretic peptide (BNP) and NT-proBNP in
screening for pulmonary arterial hypertension in patients with
systemic sclerosis. J Rheumatol. 37:2064–2070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cengiz M, Yavuzer S, Kılıçkıran Avcı B,
Yürüyen M, Yavuzer H, Dikici SA, Karataş OF, Özen M, Uzun H and
Öngen Z: Circulating miR-21 and eNOS in subclinical atherosclerosis
in patients with hypertension. Clin Exp Hypertens. 37:643–649.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chambela MC, Mediano MFF, Ferreira RR,
Japiassú AM, Waghabi MC, da Silva GMS and Saraiva RM: Correlation
of 6-min walk test with left ventricular function and quality of
life in heart failure due to Chagas disease. Trop Med Int Health.
22:1314–1321. 2017. View Article : Google Scholar : PubMed/NCBI
|
